Małgorzata Domagała-Haduch

Original paper Prognostic value of PIK3CA mutation status, PTEN and androgen receptor expression for metastasis-free survival in HER2-positive breast cancer patients treated with trastuzumab in adjuvant setting

Agnieszka Adamczyk, Joanna Niemiec, Anna Janecka et al. · Polish Journal of Pathology · 2015 · 25 citations · Full text

Relationship between <em>HER2</em> gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment

Agnieszka Adamczyk, Anna Kruczak, Agnieszka Harazin-Lechowska et al. · OncoTargets and Therapy · 2018 · 23 citations · Full text

Proteins Involved in HER2 Signalling Pathway, Their Relations and Influence on Metastasis-Free Survival in HER2-Positive Breast Cancer Patients Treated with Trastuzumab in Adjuvant Setting

Agnieszka Adamczyk, Aleksandra Grela-Wojewoda, Małgorzata Domagała-Haduch et al. · Journal of Cancer · 2016 · 18 citations · Full text

Analysis of adverse events of sunitinib in patients treated for advanced renal cell carcinoma

Małgorzata Domagała-Haduch, Ida Cedrych, Marek Jasiówka et al. · Archives of Medical Science · 2016 · 14 citations · Full text

Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy

Bożena Cybulska-Stopa, Iwona Ługowska, Rafał Wiśniowski et al. · Współczesna Onkologia · 2020 · 14 citations · Full text